Search Results - "Sreenivasan, Thiagarajan"
-
1
Radiotherapy with or without Chemotherapy in Muscle-Invasive Bladder Cancer
Published in The New England journal of medicine (19-04-2012)“…Management of muscle-invasive bladder cancer with radiation is associated with a 45% local relapse rate at 2 years. Concurrent treatment with mitomycin C and…”
Get full text
Journal Article -
2
Annexins in human breast cancer: Possible predictors of pathological response to neoadjuvant chemotherapy
Published in European journal of cancer (1990) (01-05-2009)“…Abstract Neoadjuvant chemotherapy is used in women who have large or locally advanced breast cancers. However, up to 70% of women who receive neoadjuvant…”
Get full text
Journal Article -
3
Generation in vivo of peptide-specific cytotoxic T cells and presence of regulatory T cells during vaccination with hTERT (class I and II) peptide-pulsed DCs
Published in Journal of translational medicine (19-03-2009)“…Optimal techniques for DC generation for immunotherapy in cancer are yet to be established. Study aims were to evaluate: (i) DC activation/maturation milieu…”
Get full text
Journal Article -
4
Abiraterone acetate and prednisolone with or without enzalutamide for high-risk non-metastatic prostate cancer: a meta-analysis of primary results from two randomised controlled phase 3 trials of the STAMPEDE platform protocol
Published in The Lancet (British edition) (29-01-2022)“…Men with high-risk non-metastatic prostate cancer are treated with androgen-deprivation therapy (ADT) for 3 years, often combined with radiotherapy. We…”
Get full text
Journal Article -
5
Chemoradiotherapy in Muscle-invasive Bladder Cancer: 10-yr Follow-up of the Phase 3 Randomised Controlled BC2001 Trial
Published in European urology (01-09-2022)“…BC2001, the largest randomised trial of bladder-sparing treatment for muscle-invasive bladder cancer (MIBC), demonstrated improvement in locoregional control…”
Get full text
Journal Article -
6
Outcomes in Patients with Muscle-invasive Bladder Cancer Treated with Neoadjuvant Chemotherapy Followed by (Chemo)radiotherapy in the BC2001 Trial
Published in European urology (01-02-2021)“…BC2001 demonstrated improved local control with the addition of chemotherapy to radiotherapy in 360 patients with muscle-invasive bladder cancer. To establish…”
Get full text
Journal Article -
7
Imaging Modality and Frequency in Surveillance of Stage I Seminoma Testicular Cancer: Results From a Randomized, Phase III, Noninferiority Trial (TRISST)
Published in Journal of clinical oncology (01-08-2022)“…Survival in stage I seminoma is almost 100%. Computed tomography (CT) surveillance is an international standard of care, avoiding adjuvant therapy. In this…”
Get full text
Journal Article -
8
Abiraterone acetate plus prednisolone with or without enzalutamide for patients with metastatic prostate cancer starting androgen deprivation therapy: final results from two randomised phase 3 trials of the STAMPEDE platform protocol
Published in The lancet oncology (01-05-2023)“…Abiraterone acetate plus prednisolone (herein referred to as abiraterone) or enzalutamide added at the start of androgen deprivation therapy improves outcomes…”
Get full text
Journal Article -
9
Runs of homozygosity and testicular cancer risk
Published in Andrology (Oxford) (01-07-2019)“…Background Testicular germ cell tumour (TGCT) is highly heritable but > 50% of the genetic risk remains unexplained. Epidemiological observation of greater…”
Get full text
Journal Article -
10
Annexins in human breast cancer: Possible predictors of pathological response to neoadjuvant
Published in European Journal of Cancer (01-05-2009)“…Neoadjuvant chemotherapy is used in women who have large or locally advanced breast cancers. However, up…”
Get full text
Journal Article -
11
Malignant melanoma and renal cell carcinoma: immunological and haematological effects of recombinant human interleukin-2
Published in European journal of cancer (1990) (01-01-1991)“…The immunological and haematological effects of continuous infusion of recombinant human interleukin-2 (rhIL-2) in 6 patients with metastatic melanoma and 6…”
Get more information
Journal Article